These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3607381)

  • 1. Gout and hyperuricaemia in systemic lupus erythematosus.
    Frocht A; Leek JC; Robbins DL
    Br J Rheumatol; 1987 Aug; 26(4):303-6. PubMed ID: 3607381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allopurinol hypersensitivity in a patient with coexistent systemic lupus erythematosus and tophaceous gout.
    McDonald J; Fam AG; Paton T; Senn J
    J Rheumatol; 1988; 15(5):865-8. PubMed ID: 3172103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tophaceous gout in patients with systemic lupus erythematosus.
    Bradley JD; Pinals RS
    Clin Exp Rheumatol; 1984; 2(2):151-5. PubMed ID: 6532619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tophaceous gout in young patients with systemic lupus erythematosus.
    Veerapen K; Schumacher HR; van Linthoudt D; Neilson EG; Wang F
    J Rheumatol; 1993 Apr; 20(4):721-4. PubMed ID: 8496872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gout in systemic lupus erythematosus and overlap syndrome - a hospital-based study.
    Ho HH; Lin JL; Wu YJ; Yu KH; Chen JY; Luo SF
    Clin Rheumatol; 2003 Oct; 22(4-5):295-8. PubMed ID: 14579159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Simultaneous incidence of systemic lupus erythematosus and gout].
    Kalmár L; Ablonczy E; Müzes G; Neumark T; Répay I; Gergely P
    Orv Hetil; 1982 Aug; 123(32):1977-81. PubMed ID: 7145385
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic lupus erythematosus and gout.
    Greenfield DI; Fong JS; Barth WF
    Semin Arthritis Rheum; 1985 Feb; 14(3):176-9. PubMed ID: 4081786
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical and genetic features of diuretic-associated gout: a case-control study.
    Mitnala S; Phipps-Green A; Franklin C; Horne A; Stamp LK; Merriman TR; Dalbeth N
    Rheumatology (Oxford); 2016 Jul; 55(7):1172-6. PubMed ID: 26989110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diuretic induced gout: a multifactorial condition.
    Scott JT; Higgens CS
    Ann Rheum Dis; 1992 Feb; 51(2):259-61. PubMed ID: 1550414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute gouty arthritis and systemic lupus erythematosus.
    Lally EV; Parker VS; Kaplan SR
    J Rheumatol; 1982; 9(2):308-10. PubMed ID: 7097694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexistent systemic lupus erythematosus and tophaceous gout.
    DeCastro P; Jorizzo JL; Solomon AR; Lisse JR; Daniels JC
    J Am Acad Dermatol; 1985 Oct; 13(4):650-4. PubMed ID: 4078053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic lupus erythematosus and gouty arthritis: an uncommon association.
    Bajaj S; Fessler BJ; Alarcón GS
    Rheumatology (Oxford); 2004 Mar; 43(3):349-52. PubMed ID: 14963203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lupus nephritis is associated with more corticosteroid-associated organ damage but less corticosteroid non-associated organ damage.
    Joo YB; Won S; Choi CB; Bae SC
    Lupus; 2017 May; 26(6):598-605. PubMed ID: 27687027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of asymptomatic hyperuricaemia and serum uric acid levels with arterial stiffness in women with systemic lupus erythematosus without clinically evident atherosclerotic cardiovascular disease.
    Sabio JM; Vargas-Hitos JA; Mediavilla JD; Navarrete-Navarrete N; Zamora-Posadas M; Pérez-Vicente S; Hidalgo-Tenorio C; Díaz-Chamorro A; Jáimez L; Jiménez-Alonso J;
    Lupus; 2010 Apr; 19(5):591-8. PubMed ID: 20179170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistent systemic lupus erythematosus and urate deposition.
    Tsuboi R; Taneda A; Ogawa H
    J Am Acad Dermatol; 1986 Nov; 15(5 Pt 1):1050-1. PubMed ID: 3782520
    [No Abstract]   [Full Text] [Related]  

  • 16. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature.
    Baranowska-Daca E; Choi YJ; Barrios R; Nassar G; Suki WN; Truong LD
    Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical characteristics of 4 cases of scleritis associated with systemic lupus erythematosus].
    Wang L; Yang Y; Jia Y; Miao H; Zhou YS; Zhang XY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1081-1085. PubMed ID: 27987518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum soluble toll-like receptor 2: a novel biomarker for systemic lupus erythematosus disease activity and lupus-related cardiovascular dysfunction.
    Houssen ME; El-Mahdy RH; Shahin DA
    Int J Rheum Dis; 2016 Jul; 19(7):685-92. PubMed ID: 25123610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANA-negative SLE presenting with nephritis and oculomotor palsy--a case report.
    Sircar S; Taneja VA; Kansra U
    Indian J Pathol Microbiol; 1997 Oct; 40(4):539-42. PubMed ID: 9444868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistent gout and systemic lupus erythematosus.
    Moidel RA; Good AE
    Arthritis Rheum; 1981 Jul; 24(7):969-71. PubMed ID: 7259808
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.